Increase (Decrease) in Accounts and Other Receivables
Eli Lilly Increase (Decrease) in Accounts and Other Receivables remained flat by 0.0% to $1.75B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 224.8%, from $538.75M to $1.75B. Over 4 years (FY 2021 to FY 2025), Increase (Decrease) in Accounts and Other Receivables shows an upward trend with a 53.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A decrease is generally positive as it indicates efficient collection of cash from customers.
Detailed definition
This metric measures the change in the amount owed to the company by customers for goods or services delivered. An incre...
Peer comparison
Standard working capital metric; peers in the energy sector often have cyclical receivables based on commodity prices.
operating_increase_decrease_in_accounts_and_other_receivablesHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.28B | $299.60M | $2.45B | $2.16B | $7.00B |
| YoY Change | — | -76.6% | +718.1% | -12.1% | +224.8% |
Increase (Decrease) in Accounts and Other Receivables at Other Companies
Frequently Asked Questions
- What is Eli Lilly's increase (decrease) in accounts and other receivables?
- Eli Lilly (LLY) reported increase (decrease) in accounts and other receivables of $1.75B in Q4 2025.
- How has Eli Lilly's increase (decrease) in accounts and other receivables changed year-over-year?
- Eli Lilly's increase (decrease) in accounts and other receivables increased by 224.8% year-over-year, from $538.75M to $1.75B.
- What is the long-term trend for Eli Lilly's increase (decrease) in accounts and other receivables?
- Over 4 years (2021 to 2025), Eli Lilly's increase (decrease) in accounts and other receivables has grown at a 53.0% compound annual growth rate (CAGR), from $1.28B to $7.00B.
- What does increase (decrease) in accounts and other receivables mean?
- The change in cash tied up in unpaid customer invoices.